Mycelium-based composites (MBCs) have emerged as promising biofabricated materials that align with circular economy and clean technology goals by utilizing fungal networks to transform lignocellulosic residues into functional, biodegradable composites. Despite the MBC’s potentials, the intrinsic nature of the fungal strain, substrate physico-chemical composition and engineering property variability remain significant hurdles that should be critically surmounted. Substrate treatment is central to determining growth kinetics, microstructural uniformity, and mechanical performance in MBC production. This review highlights recent advancements in physical, chemical, biological, and hybrid pretreatment methods, including comminution, pasteurization, alkali hydrolysis, enzymatic conditioning, microwave-assisted hydrolysis, ultrasound pretreatment, steam explosion, plasma activation, and irradiation. These technologies collectively enhance substrate digestibility, aeration, and permeability while reducing contamination. Optimization parameters—temperature, pH, C:N ratio, moisture content, particle size, porosity, and aeration—are examined as critical process levers influencing hyphal density, bonding efficiency, and composite uniformity. Evidence suggests that properly engineered substrate treatments accelerate colonization, strengthen hyphal networks, and significantly improve compressive, tensile, and flexural material properties. The review discusses emerging process control tools such as AI-assisted modeling, micro-CT porosity analysis, and sensor-integrated bioreactors that enable reproducible and energy-efficient fabrication. Collectively, the findings position substrate engineering as a foundational technology for scaling high-performance mycelium composites and advancing sustainable material innovation.
Liadi et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: